Python Tamer, Website Baker
PAIRE
PAIRE has developed Pionus, a Software as a Medical Device that utilizes AI to automatically detect, segment, and quantify anomalies in FDG PET-CT examinations. This technology enhances diagnostic accuracy and efficiency for nuclear physicians by reducing the time spent on repetitive tasks and providing new clinical indicators.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Software Only
Updated 11 months ago
Funding
Raised to date
$1.9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 1 round
ALSMCPB
$1.9M · Seed
Announced Oct 2023
Disclosed cumulative: $1.9M
RoundDateAmountValuationInvestors
Founders
Product
Problem
Nuclear medicine faces increasing strain due to technical innovations, growing demand, and a limited number of physicians. This overload can impact diagnostic accuracy and efficiency in PET-CT examinations.
Solution
PAIRE addresses this challenge with Pionus, a Software as a Medical Device (SaMD) that leverages AI to automate the detection, segmentation, and quantification of anomalies in FDG PET-CT scans. Pionus enhances diagnostic accuracy by providing new clinical indicators and reduces the time spent on repetitive tasks. The AI-powered solution optimizes diagnostic processes, supporting the development of personalized precision medicine and improving patient care. By increasing diagnostic accuracy and reducing operational complexity, Pionus aims to steer nuclear medicine into a new era of greater efficiency and accessibility.
Target Audience
The primary users are nuclear physicians and healthcare systems seeking to optimize diagnostic processes, improve patient care, and alleviate the burden on the current healthcare system.
Features
- AI-driven automatic detection, segmentation, and quantification of anomalies in FDG PET-CT examinations
- Provides additional security to exam reading, preventing errors
- Offers access to new essential indicators in clinical routine
- Reduces redundant and time-consuming tasks, saving time for nuclear physicians
- Supports the development of theranostic therapies and personalized precision medicine
- CE marking under the European Medical Device Regulation (MDR 2017/745) and ISO 13485 certification